MDNAF (Medicenna Therapeutics) Float Percentage Of Total Shares Outstanding: 41.46% (As of Jul. 03, 2026)


MDNAF Medicenna Therapeutics Corp MDNAF
29 GF Score
Price $0.28
! 1 Warning Sign
View Full Analysis

What is Medicenna Therapeutics Float Percentage Of Total Shares Outstanding?

Medicenna Therapeutics MDNAF -8.64% 29 Float Percentage Of Total Shares Outstanding is 41.46% as of Jul. 03, 2026. GuruFocus rates MDNAF with a GF Score™ of 29/100. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medicenna Therapeutics's float shares is 38.27 Mil. Medicenna Therapeutics's total shares outstanding is 92.30 Mil. Medicenna Therapeutics's float percentage of total shares outstanding is 41.46%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medicenna Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medicenna Therapeutics's Institutional Ownership is 0.22%.

MDNAF
29GF Score
Medicenna Therapeutics Corp MDNAF
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicenna Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Medicenna Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=38.27/92.30
=41.46%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 41.46% mean?
Medicenna Therapeutics (MDNAF) has a Float Percentage Of Total Shares Outstanding of 41.46% as of Jul. 03, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Medicenna Therapeutics and its competitors.
Is Medicenna Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Medicenna Therapeutics' current Float Percentage Of Total Shares Outstanding is 41.46%. Overall, Medicenna Therapeutics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Medicenna Therapeutics' Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Medicenna Therapeutics' Float Percentage Of Total Shares Outstanding of 41.46% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Medicenna Therapeutics and its competitors. Medicenna Therapeutics's current Float Percentage Of Total Shares Outstanding is 41.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicenna Therapeutics stock overvalued right now?
Medicenna Therapeutics (MDNAF) has a current Float Percentage Of Total Shares Outstanding of 41.46%. The current Float Percentage Of Total Shares Outstanding is 41.46%. Medicenna Therapeutics' overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Medicenna Therapeutics (MDNAF), the current Float Percentage Of Total Shares Outstanding is 41.46% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicenna Therapeutics Business Description

Other Exchanges MDNA:Canada
Address 2 Bloor Street West, Suite 903, Toronto, ON, CAN, M4W 3E2
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL-13 Superkines and Empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. Its pipeline candidates include MDNA11 for Cancer immunotherapies, MDNA55 is a Molecular Trojan Horse, and BiSKITs represent a novel platform comprised of Bifunctional SuperKine ImmunoTherapies.
29GF Score

Get the complete analysis for MDNAF

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price